Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Bovine Cytokeratin 7 (CK7) Monoclonal Antibody

Cat. No.VD8N71

Product TypeAnimal-targeted Antibodies

Size

Product Overview

BioVenic mouse monoclonal antibody is specific for bovine cytokeratin 7. It can be applied to WB, IF and ICC assays of bovine cytokeratin 7.

Specifications

Application WB; IF; ICC
Clonality Monoclonal
Classification Primary Antibody
Clone G3N35
Host Mouse
Target Species Bovine
Species Reactivity Bovine
Specificity Bovine Cytokeratin 7
Isotype IgG
Immunogen Purified recombinant bovine cytokeratin 7 (N-terminus) protein fragments
Concentration 1 mg/mL
Conjugation Unconjugated
Physical State Liquid

Target Information

Cytokeratin 7 (CK7) is a type II intermediate filament protein that contributes to the mechanical stability of epithelial cells. It is expressed in various tissues, including the lungs, breast, ovaries, and parts of the gastrointestinal tract. CK7, along with other cytokeratins, forms a network of intermediate filaments that provide structural support to cells and help maintain their shape and resistance to mechanical stress.

Target Bovine Cytokeratin 7
Target Synonym KRT7; SCL
Gene ID 535697
UniProt ID Q29S21

Shipping and Storage

This product is shipped with ice gel packs. Store at -20°C (up to 12 months) on receipt. Avoid repeated freezing and thawing as this may denature the antibody.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Dum, David, et al. "Cytokeratin 7 and cytokeratin 20 expression in cancer: a tissue microarray study on 15,424 cancers." Experimental and molecular pathology 126 (2022): 104762.
Inquiry Basket